VOV.VN - The first doses of the AstraZeneca COVID-19 vaccine produced in the Republic of Korea (RoK), will be injected into local people from March 8, said Health Minister Nguyen Thanh Long at a meeting of the National Steering Committee for COVID-19 Prevention and Control on March 5.

Thailand has received the first 200,00 doses of COVID-19 vaccine from China’s pharmaceutical manufacturer Sinovac Biotech, and the Government has worked out a plan for COVID-19 vaccine management and distribution.

VOV.VN - Vietnam confirmed three new imported cases of COVID-19 on March 3 morning, raising the national tally of imported cases to 914, according to the National Steering Committee for COVID-19 Prevention and Control.

VOV.VN - Prime Minister Nguyen Xuan Phuc has requested that the Ministry of Health (MoH) speed up the pace of the national vaccination campaign in order to ensure that it is launched this week.

Private investment is forecast to keep flowing into the healthcare sector in the time ahead with the appearance of many new drivers, according to the Dau tu (Vietnam Investment Review) newspaper.

VOV.VN - The national vaccination campaign against the novel coronavirus (COVID-19) may be delayed slightly due to the need to check the quality of the vaccine, according to Minister of Health Nguyen Thanh Long.

VOV.VN - Nano Covax, Vietnam’s first locally-produced COVID-19 vaccine, has elicited a host of antibodies that help to protect those injected against the B.1.1.7 variant of the SARS-CoV-2 virus which originates from the UK, according to a leading Vietnamese scientist.

VOV.VN - A number of domestic businesses have announced their plans to purchase novel coronavirus (COVID-19) vaccines for use among their employees and family members following the arrival of the first batch of the AstraZeneca vaccine.

VOV.VN - The Ministry of Health is considering importing two more COVID-19 vaccines produced by Moderna of the United States and Generium of Russia.

VOV.VN - The nation is projected to receive 150 million doses of novel coronavirus (COVID-19) vaccines from foreign and domestic sources by 2022, with seven batches being supplied by British-Swedish firm AstraZeneca, global vaccine access mechanism COVAX, and other domestic producers.